Jones Financial Companies’s Blueprint Medicines BPMC Stock Holding History

Jones Financial Companies’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9	Closed	-$1.15K	–	4241
2025 Q2	$1.15K	Sell	9 -7	-44%	-$727	﹤0.01%	3623
2025 Q1	$1.42K	Buy	+16	New	+$1.56K	﹤0.01%	3324

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jones Financial Companies's BPMC Position: Q3 2025 in Review

Jones Financial Companies sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 9 shares — an estimated $1.15K sold.

Jones Financial Companies first reported a position in BPMC in Q1 2025 and held it in 2 quarters. The position peaked at $1.42K in Q1 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Jones Financial Companies reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Jones Financial Companies sold 9 Blueprint Medicines shares in Q3 2025, an estimated $1.15K.
Jones Financial Companies first reported a position in Blueprint Medicines in Q1 2025 and held it in 2 quarters.
Jones Financial Companies's Blueprint Medicines position peaked at $1.42K in Q1 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Jones Financial Companies's 13F filing for Q3 2025, filed 4 Nov 2025.